
    
      This is a 1:1 randomized, double-masked (blind), placebo-controlled, multicenter trial with 2
      treatment arms:

        -  German Cockroach Subcutaneous Immunotherapy (SCIT) + guideline-based standard asthma
           care, OR

        -  Placebo (for German Cockroach Subcutaneous Immunotherapy [SCIT]) + guideline-based
           standard asthma care

      Eighty participants 8 to 17 years of age who are sensitized to cockroach, have asthma, and a
      positive cockroach Nasal Allergen Challenge (NAC) before treatment randomization will be
      enrolled.
    
  